Industry Update: Eli Lilly to Acquire Orna Therapeutics to Advance Cell Therapies
Industry Update: Providence Therapeutics Commences mRNA PCV Trial in Australia for Brain Cancers
Industry Update: CREATE Medicines Demonstrates B-Cell Depletion & Repeatable Dosing with In Vivo CAR-T
Industry Update: NeuCyte & Grann Pharma Enter Partnership for mRNA-Based Therapies for Rare Neurological Diseases
Industry Update: Adjuva Bio Awarded CELLSCRIPT™ 2026 mRNA Research Grant to Enhance Next-Gen In Vivo Cell Therapies

Yingzhong Li

Yingzhong Li

President SunVax mRNA Therapeutics

Seminars

Tuesday 21st July 2026

Cell-Type-Specific Delivery Beyond In Vivo CAR-T

4:15 pm

Ionizable lipids suitable for cell type specific delivery
Delivery efficacies beyond LNP
Applications of cell-type-specific delivery beyond in vivo CAR-T

Yingzhong

View all Speakers

View Event Brochure